Cell and Gene Therapy CRO Market
完整報告名稱與涵蓋範圍
Cell and Gene Therapy CRO Market Size, Share & Trends Analysis Report, By Type of Cell Therapy (CAR-NK, CAR-T, TCR-T, and Others), By Type of Genetic Modification (Ex vivo and In vivo), By Stage of Development (Discovery, Preclinical, and Clinical)), By Therapeutic Area, By End-user, By Region, Forecasts, 2024-2031
報告摘要
Valued at USD 1.46 Bn as of 2023, the global Cell and Gene Therapy CRO Market is expected to climb to USD 2.43 Bn by 2031, reflecting a compound annual growth rate of 6.7% over the 2024–2031 period.
Cell and Gene Therapy CRO encompasses manipulating a patient's cells to introduce, remove, or alter specific genes in order to correct genetic problems. The sector has gained traction as organizations seek innovative approaches to address evolving healthcare challenges.
Market momentum is bolstered by mounting call for advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
From a regional perspective, mature markets in North America and Europe continue to hold substantial shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and mounting investment in the sector.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Cell and Gene Therapy CRO Market Snapshot
Chapter 4. Global Cell and Gene Therapy CRO Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Type of Cell Therapy Estimates & Trend Analysis
5.1. by Type of Cell Therapy & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Type of Cell Therapy:
5.2.1. CAR-NK
5.2.2. CAR-T
5.2.3. TCR-T
5.2.4. Others
Chapter 6. Market Segmentation 2: by Type of Genetic Modification Estimates & Trend Analysis
6.1. by Type of Genetic Modification& Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Type of Genetic Modification:
6.2.1. Ex vivo
6.2.2. In vivo
Chapter 7. Market Segmentation 3: by Stage of Development Estimates & Trend Analysis
7.1. by Stage of Development & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Stage of Development:
7.2.1. Discovery
7.2.2. Preclinical
7.2.3. Clinical
Chapter 8. Market Segmentation 4: by Therapeutic Area Estimates & Trend Analysis
8.1. by Therapeutic Area & Market Share, 2019 & 2031
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Therapeutic Area:
8.2.1. Blood Disorders
8.2.2. Cardiovascular Disorders
8.2.3. Dermatological Disorders
8.2.4. Immunological Disorders
8.2.5. Infectious Diseases
8.2.6. Metabolic Disorders
8.2.7. Musculoskeletal Disorders
8.2.8. Neurological Disorders
8.2.9. Oncological Disorders
8.2.10. Rare Diseases
8.2.11. Other disorders
Chapter 9. Market Segmentation 5: by End-User Estimates & Trend Analysis
9.1. by End-User & Market Share, 2019 & 2031
9.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End-User:
9.2.1. Industry Players
9.2.2. Non-Industry Players
Chapter 10. Cell and Gene Therapy CRO Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. North America
10.1.1. North America Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by Type of Cell Therapy, 2019-2031
10.1.2. North America Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by Type of Genetic Modification,2019-2031
10.1.3. North America Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by Stage of Development ,2019-2031
10.1.4. North America Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area ,2019-2031
10.1.5. North America Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2019-2031
10.1.6. North America Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
10.2. Europe
10.2.1. Europe Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by Type of Cell Therapy, 2019-2031
10.2.2. Europe Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by Type of Genetic Modification ,2019-2031
10.2.3. Europe Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by Stage of Development ,2019-2031
10.2.4. Europe Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2019-2031
10.2.5. Europe Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2019-2031
10.2.6. Europe Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
10.3. Asia Pacific
10.3.1. Asia Pacific Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by Type of Cell Therapy, 2019-2031
10.3.2. Asia Pacific Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by Type of Genetic Modification,2019-2031
10.3.3. Asia-Pacific Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by Stage of Development ,2019-2031
10.3.4. Asia Pacific Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2019-2031
10.3.5. Asia Pacific Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2019-2031
10.3.6. Asia Pacific Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
10.4. Latin America
10.4.1. Latin America Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by Type of Cell Therapy, 2019-2031
10.4.2. Latin America Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by Type of Genetic Modification, 2019-2031
10.4.3. Latin America Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by Stage of Development ,2019-2031
10.4.4. Latin America Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area ,2019-2031
10.4.5. Latin America Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2019-2031
10.4.6. Latin America Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
10.5. Middle East & Africa
10.5.1. Middle East & Africa Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by Type of Cell Therapy, 2019-2031
10.5.2. Middle East & Africa Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by Type of Genetic Modification, 2019-2031
10.5.3. Middle East & Africa Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by Stage of Development, 2019-2031
10.5.4. Middle East & Africa Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area ,2019-2031
10.5.5. Middle East & Africa Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2019-2031
10.5.6. Middle East & Africa Cell and Gene Therapy CRO Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. Altasciences
11.2.2. Allucent
11.2.3. CMIC
11.2.4. Labcorp
11.2.5. Linical
11.2.6. Medpace
11.2.7. PPD
11.2.8. Precision for Medicine
11.2.9. QPS
11.2.10. Syneos Health
11.2.11. CMED
11.2.12. ICON
11.2.13. Pharmalex
11.2.14. Novotech
11.2.15. Other Prominent Players
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們